Stocks News

LAST PRICE
20.3000
TODAY'S CHANGE (%)
Trending Up4.7100 (30.2117%)

Bid / Lots
20.0800/ 1
Ask / Lots
20.4800/ 1
Open / Previous Close
15.4800 / 15.5900
Day Range
Low 15.4800
High 20.9300
52 Week Range
Low 12.4900
High 74.4900
Volume
1,062,923
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE, from 10 hours ago by Accesswire
  10 hours ago by Accesswire
  Companies Mentioned: NGNE
  NEW YORK, NY / ACCESSWIRE / November 22, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Neurogene Inc. ("Neurogene" or the "Company") (NASDAQ:NGNE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: NGNE
  
  NEW YORK, NY / ACCESSWIRE / November 22, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Neurogene Inc. ("Neurogene" or the "Company") (NASDAQ:NGNE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Stockholders to Inquire about Securities Investigation, from 10 hours ago by Accesswire
  10 hours ago by Accesswire
  Companies Mentioned: NGNE
  NEW YORK CITY, NY / ACCESSWIRE / November 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neurogene Inc. ("Neurogene" or "the Company") (NASDAQ:NGNE). Investors who purchased Neurogene securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NGNE.
- Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Stockholders to Inquire about Securities Investigation, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: NGNE
  
  NEW YORK CITY, NY / ACCESSWIRE / November 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neurogene Inc. ("Neurogene" or "the Company") (NASDAQ:NGNE). Investors who purchased Neurogene securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NGNE.
Yesterday
- Neurogene Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Neurogene Inc. (NGNE), from 2:08PM ET on Thursday Nov 21, 2024 by Accesswire
  2:08PM ET on Thursday Nov 21, 2024 by Accesswire
  Companies Mentioned: NGNE
  NEW YORK, NY / ACCESSWIRE / November 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neurogene Inc. ("Neurogene Inc.") (NASDAQ:NGNE) concerning possible violations of federal securities laws.

Yesterday
- Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm, from 1:14PM ET on Thursday Nov 21, 2024 by Dow Jones
  1:14PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: ZNTL
- DJ Biomea Fusion Price Target Maintained With a $40.00/Share by HC Wainwright & Co., from 6:22AM ET on Thursday Nov 21, 2024 by Dow Jones
  6:22AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: BMEA
Nov 20, 2024
- DJ Eledon Pharmaceuticals Price Target Maintained With a $16.00/Share by HC Wainwright & Co., from 8:27AM ET on Wednesday Nov 20, 2024 by Dow Jones
  8:27AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: ELDN
Nov 19, 2024
- DJ Biomea Fusion Is Maintained at Buy by D. Boral Capital, from 1:02PM ET on Tuesday Nov 19, 2024 by Dow Jones
  1:02PM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: BMEA
Nov 18, 2024
- Late-Breaker Oral Presentation Showing New Analysis from the Escalation Portion of COVALENT-111 Presented at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024), from 8:00AM ET on Monday Nov 18, 2024 by Dow Jones
  8:00AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: BMEA
Nov 15, 2024
- DJ Zentalis Pharmaceuticals Is Maintained at Buy by Guggenheim, from 2:18PM ET on Friday Nov 15, 2024 by Dow Jones
  2:18PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ZNTL
- DJ Zentalis Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co., from 6:54AM ET on Friday Nov 15, 2024 by Dow Jones
  6:54AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ZNTL
Nov 14, 2024
- Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update, from 4:30PM ET on Thursday Nov 14, 2024 by Dow Jones
  4:30PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: BNTC
- Press Release: Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update, from 4:30PM ET on Thursday Nov 14, 2024 by Dow Jones
  4:30PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: BNTC
Nov 13, 2024
- Zentalis Pharmaceuticals Appoints Julie Eastland as CEO, from 8:56AM ET on Wednesday Nov 13, 2024 by MT Newswires
  8:56AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: MRK, ZNTL

Neurogene Inc
NASDAQ:NGNEUnited States

Search Criteria

Today

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE, from 10 hours ago by Accesswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE, from 10 hours ago by Dow Jones

Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Stockholders to Inquire about Securities Investigation, from 10 hours ago by Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Stockholders to Inquire about Securities Investigation, from 10 hours ago by Dow Jones

Yesterday

Neurogene Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Neurogene Inc. (NGNE), from 2:08PM ET on Thursday Nov 21, 2024 by Accesswire

Peers Headlines

Yesterday

Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm, from 1:14PM ET on Thursday Nov 21, 2024 by Dow Jones

DJ Biomea Fusion Price Target Maintained With a $40.00/Share by HC Wainwright & Co., from 6:22AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

DJ Eledon Pharmaceuticals Price Target Maintained With a $16.00/Share by HC Wainwright & Co., from 8:27AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 19, 2024

DJ Biomea Fusion Is Maintained at Buy by D. Boral Capital, from 1:02PM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 18, 2024

Late-Breaker Oral Presentation Showing New Analysis from the Escalation Portion of COVALENT-111 Presented at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024), from 8:00AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 15, 2024

DJ Zentalis Pharmaceuticals Is Maintained at Buy by Guggenheim, from 2:18PM ET on Friday Nov 15, 2024 by Dow Jones

DJ Zentalis Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co., from 6:54AM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update, from 4:30PM ET on Thursday Nov 14, 2024 by Dow Jones

Press Release: Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update, from 4:30PM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

Zentalis Pharmaceuticals Appoints Julie Eastland as CEO, from 8:56AM ET on Wednesday Nov 13, 2024 by MT Newswires